Edition:
United Kingdom

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

6.40USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$6.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,739
52-wk High
$8.20
52-wk Low
$2.05

Chart for

About

Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. The Company's commercial product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic and related variants of... (more)

Overall

Beta: --
Market Cap(Mil.): $244.85
Shares Outstanding(Mil.): 39.81
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Strongbridge Biopharma Q3 loss per share $0.98

* Strongbridge Biopharma Plc provides corporate update and reports third quarter 2017 financial results

14 Nov 2017

BRIEF-Strongbridge Biopharma Plc announces proposed public offering of ordinary shares

* Strongbridge Biopharma Plc announces proposed public offering of ordinary shares

03 Oct 2017

BRIEF-Armistice Capital Llc reports 5.1 percent passive stake in Strongbridge Biopharma

* Armistice Capital Llc reports 5.1 percent passive stake in Strongbridge Biopharma Plc as of Sept 12, 2017 - SEC filing Source text: (http://bit.ly/2xlELBz) Further company coverage:

22 Sep 2017

BRIEF-Strongbridge Biopharma secures $53 mln financing from CRG

* Strongbridge Biopharma Plc secures $53 million financing from crg

17 Jul 2017

Earnings vs. Estimates